MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Satellos Bioscience Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
49.7%
8M of 15M shares
Institutional holders
26
2 new, 7 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 1,725,247 | 8.30% | 13G (passive) | Mar 31, 2026 |
| Brian Matthew Bloom | 1,133,401 | 7.35% | 13G (passive) | Feb 6, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MSLE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Franklin Resources Inc | 938,666 | 6.07% | $7.23M | – | 0.00% |
| Siren, L.L.C. | 892,074 | 5.77% | $6.94M | – | 0.14% |
| Vivo Capital, LLC | 813,666 | 5.26% | $6.33M | – | 0.58% |
| Point72 Asset Management, L.P. | 682,700 | 4.42% | $5.31M | −8,078 | 0.01% |
| Sphera Funds Management Ltd. | 652,590 | 4.22% | $5.07M | +163,383 | 0.66% |
| Woodline Partners LP | 500,432 | 3.24% | $3.89M | – | 0.01% |
| Stonepine Capital Management, LLC | 491,624 | 3.18% | $3.72M | +391,624 | 2.10% |
| Suvretta Capital Management, LLC | 475,000 | 3.07% | $3.69M | – | 0.07% |
| Avidity Partners Management LP | 387,769 | 2.51% | $3.01M | −387,769 | 0.48% |
| Saturn V Capital Management LP | 350,000 | 2.26% | $2.72M | – | 0.39% |
| Soleus Capital Management, L.P. | 314,359 | 2.03% | $2.44M | −100,000 | 0.08% |
| 683 Capital Management, LLC | 230,833 | 1.49% | $1.79M | – | 0.09% |
| ADAR1 Capital Management, LLC | 222,555 | 1.44% | $1.73M | – | 0.08% |
| AWM Investment Company, Inc. | 180,000 | 1.16% | $1.40M | New | 0.12% |
| Millennium Management LLC | 152,768 | 0.99% | $1.19M | −145,665 | 0.00% |
| Adage Capital Partners Gp, L.L.C. | 150,000 | 0.97% | $1.17M | −230,354 | 0.00% |
| Empery Asset Management, LP | 107,100 | 0.69% | $832.70K | −123,000 | 0.96% |
| Citadel Advisors LLC | 67,738 | 0.44% | $526.66K | +25,246 | 0.00% |
| Morgan Stanley | 25,732 | 0.17% | $200.07K | +4,549 | 0.00% |
| China Universal Asset Management Co., Ltd. | 20,000 | 0.13% | $155.50K | +13,600 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 26 | 8M | 49.7% | 2 / 6 | 7 / 7 | 1M | 1M |
| Q1 2026 | 31 | 8M | 51.7% | 31 / 0 | 0 / 0 | 8M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MSLE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | 246,407 | 1.59% | $2.46M | 0.21% | Jul 31, 2026 |
| Franklin Biotechnology Discovery Fund | 96,830 | 0.63% | $689.82K | 0.08% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 11,907 | 0.08% | $86.92K | 0.00% | May 31, 2026 |